Orforglipron is a tablet GLP-1 receptor agonist – it acts on the same appetite and fullness signals as injectable GLP-1 treatments. It should not be taken alongside another GLP-1 medicine.
Foundayo (orforglipron)
A newer once-daily weight management tablet that works on the same appetite hormones as GLP-1 injections.
From £XX
How it works
Who it may be suitable for
- Adults who meet the criteria confirmed at assessment
- Patients who would prefer a tablet to a weekly injection
- Not suitable for everyone – assessed individually
Treatment process
- 01Complete your consultation and health questionnaire
- 02Clinical assessment with our prescriber
- 03Treatment supplied where clinically appropriate
- 04Regular review and dose management
Start your Foundayo (orforglipron) consultation
A short assessment confirms whether this treatment is right for you.